Genmab — Juli 2020

[E_L]

delay seems logical , given the FDA hold

[Stroka]

For vildt. .Der strømmer købere til i disse tynde luftlag. Sælgerne holder sig tilbage.

[kkjoel]

EL, is the op-in/out deadline on a fixed date? .. thought it was linked to the clinical progress (ie end of Ph X)?

[bikube]

I U S er der også ny ATH på 34,40 = 2264Dkk. Det ggår da i det hele taget godt i dag. 5 af mine 6 største har sat ATH i dag.

[Solsen]

Ops in when Genmab have seen data. What JW told us recently.

[E_L]

i think it was , i got that from the ADCT IPO material at the time

[E_L]

ok, thks, i thought you meant it already happened and i missed it

[Solsen]

Genmab owns 25% of this antibody and has the right to potentially increase ownership based on the clinical data. We currently await further data from ADC Therapeuctics with this exciting compound.

[Solsen]

From the last PI Q&A with Genmab

[Helge_LarsenPI-redaktør]

Transcript from Q&A: https://nbg1.your-objectstorage.com/proinvestor-dev/forum/ir/cms/QA-Genmab 2020-05-11.pdf

[BioShare]

Igen en stærk luk i kurs 2.263

[E_L]

yea, i know that. prospectus more detailed https://www.sec.gov/Archives/edgar/data/1771910/000114036120009738/nt10009045x3_f1.htm

[E_L]

have fun

[Helge_LarsenPI-redaktør]

[kkjoel]

Tnx guys, for "upclearing" that

[E_L]

FDA lifts partial hold on ADC, clearing way for a 2021 readout and two potential near-term approvals https://endpts.com/fda-lifts-partial-hold-on-adc-clearing-way-for-a-2021-readout-and-two-potential-near-term-approvals/

[kkjoel]

Fra endpoints artiklen du lige linkede til: ".., it helps position the monstrously backed Swedish biotech to soon become...". UUUPS.. nå ja, amerikanere er ikke altid så geografisk koncise. Sweden, Switzerland - Tomato, Tomaaato.

[kkjoel]

Men ellers, grande cadeau, for den lynhurtige analysefremfinding.

[E_L]

;
-)

[Klarussen]

Synes at fortsætte opad i US, nu sv.t. 2272 DDK